The life sciences giant is transforming its diagnostics segment with its acquisition of Masimo Corporation, shifting from ...

Study Shows Pulse Oximetry Accurate on Hospitalized Newborns of All Skin Tones ...

"Masimo secures FDA approval for OIRD detection on wearable patient monitor" was originally created and published by Medical ...

Masimo, a Danaher company and a specialty diagnostics solutions innovator of pulse oximetry and other patient monitoring ...

The OIRD detection capability [Image courtesy of Masimo] Masimo, a Danaher (NYSE:DHR) company, today announced FDA clearance for an opioid-induced respiratory depression (OIRD) detection platform.

DHR closes its $9.9B Masimo acquisition, adding AI-enabled patient-monitoring and sensor technologies to expand diagnostics ...

Danaher Corporation (NYSE: DHR), a global science and technology innovator, announced today that it has completed the acquisition ...

Danaher Corporation (NYSE: DHR), a global science and technology innovator, announced today that it has completed the acquisition of Masimo Corporation, a leading specialty diagnostics provider of ...

Receiving FDA clearance for Nellcor with Nell-EQ could help Medtronic as it competes with Masimo for the pulse oximetry ...

Disposable Pulse Oximetry Sensors Market size was valued at USD 1.2 Billion in 2024 and is poised to grow from USD 1.4 Billion in 2025 to USD 3.2 Billion by 2033, growing at a CAGR of 10.2% during the ...

Some Pixel Watch owners say SpO2 and skin temperature tracking stopped working after a recent Fitbit update. Google and Fitbit have acknowledged the permission reset issue and say work is underway to ...

IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI) (“Masimo”), a leading global innovator in patient monitoring, today announced that its stockholders voted in favor of the proposal to ...